학술논문
No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir.
Document Type
Journal Article
Author
Source
Subject
*THERAPEUTICS
*HIV infections
*PROTEOLYTIC enzymes
*DARUNAVIR
*ATAZANAVIR
*DRUG resistance
*VIRAL mutation
*MEDICAL virology
*ANTI-HIV agents
*RITONAVIR
*HIV protease inhibitors
*COMBINATION drug therapy
*DRUG resistance in microorganisms
*HIV
*PROTEINS
*VIRAL load
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0305-7453
Abstract